Delivery Order SPE2DB20D1102-SPE2DB25FC6UQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Twinrix vaccine in syringe form, with a contract ceiling value of $4,948.52. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, with a ceiling value of $1,747.78. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 29, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, valued at $4,351.64 with a firm fixed price structure. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement of immunization products to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes valued at $2,679.52. This non-competitive, firm fixed-price delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line item procurement fulfilling federal medical supply requirements under the Defense Health...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $129,484.53 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract represents a non-set-aside procurement, indicating open competition among eligible vendors. Performance will take place at the awardee's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes valued at $1,078.23 under a firm fixed price contract. This non-set-aside award was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This delivery order represents a discrete fulfillment under the company's broader contract vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Twinrix vaccine in syringe form, with a contract value of $2,184.12 and an ultimate completion date of July 31, 2025. This non-set-aside contract utilizes firm fixed price pricing and is classified as a delivery order under the company's existing indefinite delivery contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $91,647.30 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $149,035.14 for TWINRIX vaccine in syringe format on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical medical supply needs through the federal procurement process. The contract is performed at AmerisourceBergen's corporate office location...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Twinrix vaccine in syringe form, with a contract ceiling value of $1,815.66. The contract was awarded on a firm fixed-price basis with an ultimate completion date of September 3, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, competitively awarded action with no...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB25FC6UQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, valued at $1,455.70 with a completion date of September 10, 2025. This contract is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a competitive procurement through open competition, consistent with AmerisourceBergen's established track record as a primary pharmaceutical distributor for federal medical supply needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. The IDC encompasses products across multiple therapeutic domains, supporting customers including the Defense Health Agency and other government healthcare systems through a flexible contracting structure designed to meet evolving federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/9/25 |